TrialJournal of neurology, neurosurgery, and psychiatry2022

Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits.

J Nicholas Brenton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.